proteinuria (1-5-4 g/24 h). Thirty hours before delivery her serum creatinine was 277 ,umol/l (3-1 mg/100 ml). Four days after admission labour began spontaneously and was completed in 70 minutes without complications. figure) . Reticulocytes increased to 5-7 % and haemoglobin concentration fell in 48 hours from 11-1 mmol/I (12 g/dl) to 8.2 mmolfl (8-9 g/dl). Goombs test was negative. Catheterisation 24 hours after delivery produced 1000 ml urine.
Ani
The plasma AT-IIlI concentration (Antithrombin Coatest) was very low (figure). Therefore 26 hours after delivery treatment was begun with a concentrated solution of AT-IIl prepared from a purified preparation of human AT-III (Kabi, Stockholm). First 1200 units of AT-III were given as an intravenous bolus (one unit was equivalent to the amount of AT-III/ml normal human plasma). One hour later 2750 units were infused over a period of three hours, followed by a third infusion of 250 units (figure). The AT-III concentrations were unstable. A fall on the third day required an additional infusion of 1650 units over four hours followed by a bolus injection of 150 units, and the concentration stabilised at a slightly subnormal level. During and after the AT-III infusions serum creatinine and bilirubin concentrations fell while haptoglobin and platelets soon returned to normal (figure), as did the patient's clinical condition. Kidney biopsy on the 10th day showed normal morphology. Five months later kidney function was normal and haemoglobin and AT-III concentrations were in the lower range of normal.
Comment
The aetiology of HUS is unknown, but our data suggest that a stage of disseminated intravascular coagulation (DIC) is a factor of pathogenetic significance.' Quite possibly thromboplastin escapes from the thromboplastin-rich placenta by uterine contraction during labour. Also in pregnancy sensitivity is increased to stimuli known to induce DIC.2 Interestingly infusion of AT-III can protect chicken embryos against the injection of thromboplastin.3 Similarly, heparin is reported to prevent the toxicity of thromboplastin injection in mice. But heparin increases the turnover rate of AT-III,4 and giving heparin to patients low in plasma AT-III may therefore paradoxically increase an existing risk of thrombosis.5 Therefore the low plasma AT-III concentration at the onset of the syndrome in our patient seems particularly significant, and we believe her recovery was due to the treatment with AT-III concentrate. Four normal volunteers (three men, one woman) were given 4 ltg 1,25-(OH)2D3 after an overnight fast. Three normal volunteers (two men, one woman) were given 250 ,tg 24,25-(OH)2D3 (in 0 5 ml ethanol) after an overnight fast. Blood was taken at the times indicated (see figure) and the serum stored at -20°C. Serum concentrations of both metabolites were measured in each person by a method' which gives a range of 29-168 pmol/l for 1,25-(OH)2D. and a range of 2-9-16 nmol/l for 24,25-(OH)2D3.
